Daniel Karlin, MD: Topline MM-120 Data for Generalized Anxiety Disorder
A phase 2b clinical trial met its primary endpoint with positive topline results, showing MM-120 (lysergide d-tartrate) can reduce symptoms of generalized anxiety disorder, reflected in the Hamilton Anxiety rating scale scores.
Source: hcplive.com
